HOME >> BIOLOGY >> NEWS
Men from early middle ages were nearly as tall as modern people

eople were less likely to move to warmer regions and were more likely to stick with traditional farming methods that ultimately failed," he said. "Climate change was likely to have imposed serious economic and health costs on northern Europeans, which in turn may have caused a downward trend in average height."

Urbanization and the growth of trade gained considerable momentum in the 16th and 17th centuries.

Both brought people together, which encouraged the spread of disease. And global exploration and trade led to the worldwide diffusion of many diseases into previously isolated areas.

"Height studies for the late 18th and early 19th centuries show that large cities were particularly hazardous for health," Steckel said. "Urban centers were reservoirs for the spread of communicable diseases."

Inequality in Europe grew considerably during the 16th century and stayed high until the 20th century the rich grew richer from soaring land rents while the poor paid higher prices for food, housing and land.

"In poor countries, or among the poor in moderate-income nations, large numbers of people are biologically stressed or deprived, which can lead to stunted growth," Steckel said. "It's plausible that growing inequality could have increased stress in ways that reduced average heights in the centuries immediately following the Middle Ages."

Political changes and strife also brought people together as well as put demand on resources.

"Wars decreased population density, which could be credited with improving health, but at a large cost of disrupting production and spreading disease," Steckel said. "Also, urbanization and inequality put increasing pressure on resources, which may have helped lead to a smaller stature."

Exactly why average height began to increase during the 18th and 19th centuries isn't completely clear, but Steckel surmises that climate change as well as improvements in agriculture helped. '"/>

Contact: Richard Steckel
steckel.1@osu.edu
614-292-5008
Ohio State University
1-Sep-2004


Page: 1 2 3 4

Related biology news :

1. Chemical derived from vitamin-E shows early promise as cancer drug
2. Phase II trials of second-generation antisense cancer drug planned following successful early study
3. The impact of genetic variations on the treatment of early rheumatoid arthritis
4. New research suggests early diet may play key role in protecting against childhood leukaemia
5. White House to honor UNC School of Medicine scientist for early career achievement
6. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
7. Millennia still mean early days for newly identified sex chromosome
8. Preschool bolsters early childhood immunity, reduces risk of young adult Hodgkins lymphoma
9. OHSU researchers discover possible method for early detection, prevention of premature birth
10. Register early for the AIUM regional course, Ultrasound: The Complete Perspective, and save
11. Growth study of wild chimpanzees challenges assumptions about early humans

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Men from early middle ages were nearly tall modern people

(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... 2015 Research and ... of the "Global Biosimilars Market, 2015 - ... The Global Biosimilars Market, 2015 - 2025, report ... biosimilars market. With the blockbuster biologics losing patent ... biosimilars are being viewed as viable substitutes to ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... an optimized Erk inhibitor molecule for development, thus ... a new class of potential cancer therapies. ... target for therapeutic intervention in cancer. Recently approved ... for B-Raf and Mek inhibitors. Erk inhibitors may ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: